HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
STIL
STIL centriolar assembly protein
Chromosome 1 Β· 1p33
NCBI Gene: 6491Ensembl: ENSG00000123473.17HGNC: HGNC:10879UniProt: A0A0A0MR87
99PubMed Papers
21Diseases
0Drugs
30Pathogenic Variants
FUNCTIONAL ROLE
Oncogene
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein localization to centrosomemitotic spindle organizationprotein bindingidentical protein bindingautosomal recessive primary microcephalyPrimary microcephalyT-cell acute lymphoblastic leukemiamidline interhemispheric variant of holoprosencephaly
✦AI Summary

STIL (STIL centriolar assembly protein) is an essential regulator of centriole duplication and cell cycle progression. Functionally, STIL acts as a core component of the PLK4-STIL-SAS-6 module, which initiates procentriole formation by directing the loading of structural proteins SASS6 and CPAP to the procentriole base 1. STIL is required for proper onset of centriole assembly and accurate mitotic spindle organization, with long-term silencing decreasing CDK1 activity and affecting cell survival and cell cycle distribution [UniProt]. The protein also functions as a positive regulator of sonic hedgehog signaling and, in complex with PLK4, modulates cytoskeletal rearrangements and directional cell motility. Disease relevance is substantial: mutations in STIL cause primary microcephaly 7 (autosomal recessive), exemplifying how insufficient STIL expression impairs brain development through defective centriole duplication 2. Notably, STIL deregulation exhibits a dual pathological balanceβ€”while loss-of-function mutations cause microcephaly, STIL dysregulation is also associated with cancer through chr1 instability and aberrant cell cycle control 2. STIL interacts directly with microcephaly-associated protein RTTN, and naturally occurring microcephaly mutations impair STIL-RTTN binding, blocking centriole assembly 3. This gene exemplifies how disruption of fundamental developmental processes by single genetic lesions has consequences across embryonic development and postnatal tissue homeostasis.

Sources cited
1
STIL forms core module with PLK4 and SAS-6 for centriole duplication; depletion blocks centriole formation while overexpression causes amplification
PMID: 27911707
2
STIL deregulation causes either primary microcephaly (insufficient expression) or cancer (excessive expression) through chromosomal instability
PMID: 29352115
3
STIL directly interacts with RTTN; microcephaly-associated RTTN mutation shows reduced STIL binding affinity and blocks centriole assembly
PMID: 28811500
⚠Limited data available β€” This gene has 3 indexed publications. Summary and analysis may be incomplete.
Disease Associationsβ“˜21
autosomal recessive primary microcephalyOpen Targets
0.78Strong
Primary microcephalyOpen Targets
0.46Moderate
T-cell acute lymphoblastic leukemiaOpen Targets
0.37Weak
alobar holoprosencephalyOpen Targets
0.37Weak
Cutaneous T-cell lymphomaOpen Targets
0.37Weak
lobar holoprosencephalyOpen Targets
0.37Weak
midline interhemispheric variant of holoprosencephalyOpen Targets
0.37Weak
semilobar holoprosencephalyOpen Targets
0.37Weak
septopreoptic holoprosencephalyOpen Targets
0.37Weak
T-lymphoblastic lymphomaOpen Targets
0.37Weak
unspecified peripheral T-cell lymphomaOpen Targets
0.37Weak
myoepithelial tumorOpen Targets
0.33Weak
hepatocellular carcinomaOpen Targets
0.31Weak
non-small cell lung carcinomaOpen Targets
0.30Weak
lung adenocarcinomaOpen Targets
0.30Weak
bladder transitional cell carcinomaOpen Targets
0.29Weak
urinary bladder carcinomaOpen Targets
0.29Weak
diffuse large B-cell lymphomaOpen Targets
0.28Weak
acute lymphoblastic leukemiaOpen Targets
0.28Weak
esophageal squamous cell carcinomaOpen Targets
0.28Weak
Microcephaly 7, primary, autosomal recessiveUniProt
Pathogenic Variants30
NM_001048166.1(STIL):c.1678del (p.Ser560fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 560
NM_001048166.1(STIL):c.78dup (p.Pro27fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 27
NM_001048166.1(STIL):c.2960C>G (p.Ser987Ter)Pathogenic
Microcephaly 7, primary, autosomal recessive
β˜…β˜†β˜†β˜†2025β†’ Residue 987
NM_001048166.1(STIL):c.239del (p.Leu80fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 80
NM_001048166.1(STIL):c.44+1G>TLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2025
NM_001048166.1(STIL):c.841C>T (p.Arg281Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 281
NM_001048166.1(STIL):c.1249-2A>GLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2024
NM_001048166.1(STIL):c.187C>T (p.Arg63Ter)Likely pathogenic
STIL-related disorder
β˜…β˜†β˜†β˜†2023β†’ Residue 63
NM_001048166.1(STIL):c.785+1_785+3delLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2023
NM_001048166.1(STIL):c.2433_2434del (p.Gln812fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 812
NM_001048166.1(STIL):c.2488_2489del (p.Asp830fs)Likely pathogenic
Microcephaly 7, primary, autosomal recessive
β˜…β˜†β˜†β˜†2022β†’ Residue 830
NM_001048166.1(STIL):c.384dup (p.His129fs)Likely pathogenic
Microcephaly 7, primary, autosomal recessive
β˜…β˜†β˜†β˜†2022β†’ Residue 129
NM_001048166.1(STIL):c.3538_3541del (p.Asn1180fs)Likely pathogenic
Microcephaly 7, primary, autosomal recessive
β˜…β˜†β˜†β˜†2022β†’ Residue 1180
NM_001048166.1(STIL):c.1078C>T (p.Gln360Ter)Likely pathogenic
Microcephaly 7, primary, autosomal recessive
β˜…β˜†β˜†β˜†2021β†’ Residue 360
NM_001048166.1(STIL):c.460C>T (p.Gln154Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2019β†’ Residue 154
NM_001048166.1(STIL):c.2289_2290del (p.Gln764fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2019β†’ Residue 764
NM_001048166.1(STIL):c.1092dup (p.Glu365fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2018β†’ Residue 365
NM_001048166.1(STIL):c.2830-2A>GPathogenic
not provided
β˜…β˜†β˜†β˜†2018
NM_001048166.1(STIL):c.453+5G>TLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2017
NM_001048166.1(STIL):c.703dup (p.Tyr235fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2017β†’ Residue 235
View on ClinVar β†—
Related Genes
CDK1Protein interaction98%KIF11Protein interaction98%ASPMProtein interaction97%CEP152Protein interaction97%CEP135Protein interaction96%MELKProtein interaction94%
Tissue Expression6 tissues
Bone Marrow
100%
Brain
27%
Lung
5%
Liver
5%
Ovary
5%
Heart
3%
Gene Interaction Network
Click a node to explore
STILCDK1KIF11ASPMCEP152CEP135MELK
PROTEIN STRUCTURE
Preparing viewer…
PDB5LHW Β· 0.91 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.57Moderately Constrained
pLIβ“˜
0.01Tolerant
Observed/Expected LoF0.45 [0.35–0.57]
RankingsWhere STIL stands among ~20K protein-coding genes
  • #4,860of 20,598
    Most Researched99 Β· top quartile
  • #1,804of 5,498
    Most Pathogenic Variants30
  • #3,808of 17,882
    Most Constrained (LOEUF)0.57 Β· top quartile
Genes detectedSTIL
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
PMID: 23433739
Lancet Β· 2013
1.00
2
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
PMID: 37608771
J Pathol Β· 2023
0.90
3
STIL balancing primary microcephaly and cancer.
PMID: 29352115
Cell Death Dis Β· 2018
0.80
4
PMID: 20301702
0.70
5
How robust are the STRONGER and STIL-STRONGER studies?
PMID: 36182557
Br J Anaesth Β· 2023
0.60